Cargando…

Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma

BACKGROUND: Combined whole-exome sequencing (WES) and somatic copy number alteration (SCNA) information can separate isocitrate dehydrogenase (IDH)1/2-wildtype glioblastoma into two prognostic molecular subtypes, which cannot be distinguished by epigenetic or clinical features. The potential for rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuechterlein, Nicholas, Li, Beibin, Feroze, Abdullah, Holland, Eric C, Shapiro, Linda, Haynor, David, Fink, James, Cimino, Patrick J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883769/
https://www.ncbi.nlm.nih.gov/pubmed/33615222
http://dx.doi.org/10.1093/noajnl/vdab004
_version_ 1783651280113106944
author Nuechterlein, Nicholas
Li, Beibin
Feroze, Abdullah
Holland, Eric C
Shapiro, Linda
Haynor, David
Fink, James
Cimino, Patrick J
author_facet Nuechterlein, Nicholas
Li, Beibin
Feroze, Abdullah
Holland, Eric C
Shapiro, Linda
Haynor, David
Fink, James
Cimino, Patrick J
author_sort Nuechterlein, Nicholas
collection PubMed
description BACKGROUND: Combined whole-exome sequencing (WES) and somatic copy number alteration (SCNA) information can separate isocitrate dehydrogenase (IDH)1/2-wildtype glioblastoma into two prognostic molecular subtypes, which cannot be distinguished by epigenetic or clinical features. The potential for radiographic features to discriminate between these molecular subtypes has yet to be established. METHODS: Radiologic features (n = 35 340) were extracted from 46 multisequence, pre-operative magnetic resonance imaging (MRI) scans of IDH1/2-wildtype glioblastoma patients from The Cancer Imaging Archive (TCIA), all of whom have corresponding WES/SCNA data. We developed a novel feature selection method that leverages the structure of extracted MRI features to mitigate the dimensionality challenge posed by the disparity between a large number of features and the limited patients in our cohort. Six traditional machine learning classifiers were trained to distinguish molecular subtypes using our feature selection method, which was compared to least absolute shrinkage and selection operator (LASSO) feature selection, recursive feature elimination, and variance thresholding. RESULTS: We were able to classify glioblastomas into two prognostic subgroups with a cross-validated area under the curve score of 0.80 (±0.03) using ridge logistic regression on the 15-dimensional principle component analysis (PCA) embedding of the features selected by our novel feature selection method. An interrogation of the selected features suggested that features describing contours in the T2 signal abnormality region on the T2-weighted fluid-attenuated inversion recovery (FLAIR) MRI sequence may best distinguish these two groups from one another. CONCLUSIONS: We successfully trained a machine learning model that allows for relevant targeted feature extraction from standard MRI to accurately predict molecularly-defined risk-stratifying IDH1/2-wildtype glioblastoma patient groups.
format Online
Article
Text
id pubmed-7883769
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-78837692021-02-18 Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma Nuechterlein, Nicholas Li, Beibin Feroze, Abdullah Holland, Eric C Shapiro, Linda Haynor, David Fink, James Cimino, Patrick J Neurooncol Adv Basic and Translational Investigations BACKGROUND: Combined whole-exome sequencing (WES) and somatic copy number alteration (SCNA) information can separate isocitrate dehydrogenase (IDH)1/2-wildtype glioblastoma into two prognostic molecular subtypes, which cannot be distinguished by epigenetic or clinical features. The potential for radiographic features to discriminate between these molecular subtypes has yet to be established. METHODS: Radiologic features (n = 35 340) were extracted from 46 multisequence, pre-operative magnetic resonance imaging (MRI) scans of IDH1/2-wildtype glioblastoma patients from The Cancer Imaging Archive (TCIA), all of whom have corresponding WES/SCNA data. We developed a novel feature selection method that leverages the structure of extracted MRI features to mitigate the dimensionality challenge posed by the disparity between a large number of features and the limited patients in our cohort. Six traditional machine learning classifiers were trained to distinguish molecular subtypes using our feature selection method, which was compared to least absolute shrinkage and selection operator (LASSO) feature selection, recursive feature elimination, and variance thresholding. RESULTS: We were able to classify glioblastomas into two prognostic subgroups with a cross-validated area under the curve score of 0.80 (±0.03) using ridge logistic regression on the 15-dimensional principle component analysis (PCA) embedding of the features selected by our novel feature selection method. An interrogation of the selected features suggested that features describing contours in the T2 signal abnormality region on the T2-weighted fluid-attenuated inversion recovery (FLAIR) MRI sequence may best distinguish these two groups from one another. CONCLUSIONS: We successfully trained a machine learning model that allows for relevant targeted feature extraction from standard MRI to accurately predict molecularly-defined risk-stratifying IDH1/2-wildtype glioblastoma patient groups. Oxford University Press 2021-02-15 /pmc/articles/PMC7883769/ /pubmed/33615222 http://dx.doi.org/10.1093/noajnl/vdab004 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Basic and Translational Investigations
Nuechterlein, Nicholas
Li, Beibin
Feroze, Abdullah
Holland, Eric C
Shapiro, Linda
Haynor, David
Fink, James
Cimino, Patrick J
Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma
title Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma
title_full Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma
title_fullStr Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma
title_full_unstemmed Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma
title_short Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma
title_sort radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma
topic Basic and Translational Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883769/
https://www.ncbi.nlm.nih.gov/pubmed/33615222
http://dx.doi.org/10.1093/noajnl/vdab004
work_keys_str_mv AT nuechterleinnicholas radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma
AT libeibin radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma
AT ferozeabdullah radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma
AT hollandericc radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma
AT shapirolinda radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma
AT haynordavid radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma
AT finkjames radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma
AT ciminopatrickj radiogenomicmodelingpredictssurvivalassociatedprognosticgroupsinglioblastoma